NIH-funded team developed method to identify future SARS-CoV-2 mutations that could affect rapid antigen test performance
On Sept. 15, 2022, the National Institutes of Health (NIH) announced that a research team funded by the…
On Sept. 15, 2022, the National Institutes of Health (NIH) announced that a research team funded by the…
On Aug. 22, 2021, InBios announced that laboratory studies suggest its SCoV-2 Ag Detect Rapid Test detected the…
On Jun. 30, 2021, the National Institutes of Health (NIH) announced a highly anticipated study that compared rapid…
On Jun. 11, 2021, Quidel announced today that it had received an amended Emergency Use Authorization (EUA) from…
On May 24, 2021, Quidel announced that its Sofia® SARS Antigen FIA is the first rapid antigen test…
On Mar. 30, 2021, OraSure Technologies announced that it had submitted an application to the U.S. Food and…
On Sept. 15, 2020, Soligenix, a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare…
On Aug. 19, 2020, Quidel announced that labeling for Quidel’s Emergency Use Authorization (EUA) for the Sofia SARS…
On Mar. 14, 1996, the U.S. Food and Drug Administration (FDA) announced the approval of the first antigen…